Worldwide Clinical trials for colon cancer
At Worldwide Clinical Trials, we are deeply committed to advancing the science of cancer care.
Our primary goal is to incorporate the right scientific approach with rigorous methodology. We pride ourselves on understanding the biology of disease, the global variations in patient care delivery, and country-specific regulatory requirements.
Our medical and scientific culture is intercalated in everything we do — from feasibility to final study report. Our clinical development plan is as personalized and precise as the drug being studied. Because of our unique global footprint, we are able to find the best investigators with aligned scientific interests. Our global reach allows us to access thousands of patients and we operate in geographies that provide a competitive advantage.
Our technology and processes enable us to identify the best investigators to execute the development plan. And our people — our most important asset — provide us the ability to rapidly evaluate, execute, continually assess and avoid risk.
Solid Tumor Malignancies
- Head and Neck
- Multiple myeloma and malignant plasma cell neoplasms
- Myelodysplastic syndromes
- Non-Hodgkin’s lymphoma
- Acute myelocytic leukemia
- Chronic lymphocytic leukemia
- Chronic myelogenous leukemia
- Mitotic inhibitors
- Anti-tumor antibiotics
- Alkylating agents and platinum compounds
- Hormone therapy
- Immunotherapy (e.g. cancer vaccine)
- Targeted therapies
- Biologic agents (e.g. monoclonal antibodies)
- Small molecule inhibitors (e.g. protein kinase inhibitors)
- Antisense compounds (e.g. antisense DNA)
- Antibody drug conjugates
Stemedica Posts Alzheimer's Stem Cell Data — Drug Discovery & Development
Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer's disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant ..
New partnership brings more personalized cancer treatment to Philadelphia — Phys.Org
"Our participation in the WIN consortium means Jefferson cancer patients will have access to worldwide clinical trials on promising and individualized therapies," says Massimo Cristofanilli, M.D., Director of the Jefferson Breast Care Center. "It ..
Core Science FlexCore Joint Support, Veggie Caps 90 ea
Health and Beauty (AB)
Sambucol Sambucol Black Elderberry Immune - 4 Oz